Proton pump inhibitors and odds of cholangiocarcinoma: A retrospective case‐control study

Abstract

PPI use was correlated with a significant 61% increased odds of CCA, particularly in the ECC. However, the retrospective design and observational nature cannot establish causation. Larger scale, multi-centre prospective studies are required for further validation.